How to Get Tretinoin in Delaware: Telehealth, Prescriptions, and Pharmacy Options

At a glance
- Tretinoin requires a prescription
- Delaware permits both in-person and telehealth evaluation
- Telemedicine must meet the same standard of care as an in-person visit
- A questionnaire alone is not enough to create the required clinical relationship
- Product selection depends on the diagnosis, formulation, strength, tolerance, and coverage
- Generic acne products and wrinkle-treatment products do not all share the same FDA indication
- Delaware Medicaid rules differ by fee-for-service versus managed-care enrollment
- A pharmacy outside Delaware needs a Delaware nonresident pharmacy permit to ship prescription drugs to a Delaware patient
- Compounded tretinoin is not FDA approved and should address an individual clinical need
The Basic Process
To obtain tretinoin legally in Delaware:
- Schedule an in-person or telehealth visit with a clinician authorized to treat a patient located in Delaware.
- Complete a skin and medication review sufficient to establish a diagnosis and treatment plan.
- If tretinoin is appropriate, have the prescription sent to a licensed local or mail-order pharmacy.
- Ask the pharmacy to submit the claim to insurance and explain any rejection.
- If the product is not covered, ask whether a covered strength or formulation is clinically appropriate or whether the plan offers prior authorization or a formulary exception.
Tretinoin is not a controlled substance, but it remains a prescription drug. Adapalene 0.1% is an over-the-counter topical retinoid; it is a different drug and should not be presented as prescription tretinoin.
Can a Delaware Telehealth Clinician Prescribe Tretinoin?
Yes, when the clinician and encounter satisfy Delaware law and the professional standard of care. Delaware law allows the provider-patient relationship to be established through telehealth or telemedicine. It requires identity and location checks, provider credential disclosure, consent, an appropriate diagnostic process, discussion of treatment risks and benefits, follow-up availability, and a written visit summary [1].
The law allows synchronous or asynchronous store-and-forward care when the provider determines that the same standard of care can be met. It also expressly prohibits prescribing solely in response to an internet questionnaire, internet consult, or telephone consult when a proper provider-patient relationship has not been established [1].
That means:
- a live video call is not the only lawful format in every case
- uploaded photographs can be part of an appropriate evaluation
- a form-only purchase flow is not automatically a valid medical encounter
- the clinician must be legally authorized to practice for a patient located in Delaware
- a specific platform's availability does not prove that every clinician on it is authorized in Delaware
Insurance coverage for the visit and coverage for the medication are separate questions. Do not assume a telehealth visit will have the same copay or reimbursement as an in-person visit under every plan.
Who Can Prescribe?
Delaware physicians can prescribe topical tretinoin within ordinary medical practice. Delaware APRNs receive full-practice and prescriptive authority with licensure and must practice within their role and population focus [2].
Delaware changed the title "physician assistant" to "physician associate" in May 2026. A licensed physician associate can prescribe within applicable authority; Delaware law provides a pathway for those with more than 6,000 postgraduate clinical hours to obtain independent-practice authority, while others may practice through a collaborative arrangement [3].
The practical question for a patient is not the clinician's professional title alone. Verify that the clinician is authorized to treat a patient in Delaware and that skin care falls within the clinician's scope and competence.
What the Evaluation Should Cover
Routine blood testing is not part of the FDA labeling for topical tretinoin acne products. The clinician instead needs enough information to confirm the skin condition and identify reasons to use a different plan.
The review commonly includes:
- the location and severity of acne or the exact cosmetic concern
- eczema, rosacea, sunburn, or other causes of sensitive or inflamed skin
- prescription and over-the-counter skin products
- prior reactions to retinoids or formulation ingredients
- pregnancy, plans for pregnancy, and breastfeeding
- sun exposure and use of sunscreen
Topical tretinoin is not oral isotretinoin and is not part of the iPLEDGE program. It can still cause substantial local irritation, and pregnancy-related decisions should be discussed with the prescriber rather than inferred from the rules for a different retinoid.
FDA Indications Depend on the Exact Product
It is inaccurate to say every tretinoin cream or gel is FDA approved for both acne and "photoaging."
Generic tretinoin cream in 0.025%, 0.05%, and 0.1% strengths and gel in 0.01% and 0.025% strengths is labeled for topical treatment of acne vulgaris [4]. The 2025 Retin-A Micro label covers acne vulgaris and has its own microsphere-gel strengths [5].
RENOVA 0.02% has a narrower indication: it is an adjunct to comprehensive skin care and sun avoidance for mitigation of fine facial wrinkles. Its label explicitly says it does not eliminate wrinkles, repair sun-damaged skin, or reverse photoaging, and it has not established treatment of actinic keratoses or skin cancer [6].
This distinction matters for both clinical expectations and insurance. A standard acne product used for wrinkles may be an off-label use, while a product with a fine-wrinkle indication may have different coverage or cost.
Delaware Medicaid Coverage in 2026
The Delaware Medicaid Preferred Drug List effective July 6, 2026 separates preferred and nonpreferred topical acne agents [7].
For fee-for-service members, the preferred column includes:
- tretinoin cream
- tretinoin 0.01% gel
- tretinoin 0.025% gel
The nonpreferred column includes:
- tretinoin 0.05% gel
- tretinoin microsphere products
- multiple brand and combination products
The list says two preferred products are required before a nonpreferred topical acne product will be approved. It also states that the acne-agent class is covered only through age 20 and that use in older patients is considered cosmetic [7].
The document cautions that its listed prior-authorization criteria apply to fee-for-service members. Members enrolled in Highmark Health Options, AmeriHealth Caritas Delaware, or Delaware First Health must use that managed-care organization's current criteria [7].
Therefore, the previous statement that "Delaware Medicaid covers tretinoin for acne and photoaging with prior authorization" was wrong. A member should:
- identify whether coverage is fee-for-service or through a managed-care organization
- search the current plan formulary for the exact strength and dosage form
- ask the pharmacy for the rejection code if the claim does not pay
- have the prescriber address the actual criterion rather than submit a generic PA
Commercial Insurance and Cash Prices
Commercial plans may cover generic acne products, apply an age edit, require prior authorization, exclude cosmetic use, or place a particular formulation on a nonpreferred tier. There is no reliable Delaware-wide copay, prior-authorization turnaround time, or cash-price range.
Before the visit or fill, ask:
- Is this exact NDC or product covered?
- Does coverage change by age or diagnosis?
- Is prior authorization, step therapy, or a quantity limit attached?
- Is a different generic manufacturer, formulation, or strength preferred?
- Which pharmacies are in network?
- Will a cash purchase count toward the deductible or out-of-pocket maximum?
Discount-card prices are cash transactions rather than an insurance benefit. Terms and prices can change, and a cash claim ordinarily is not combined with insurance for the same fill.
Local, Mail-Order, and Prescription Transfers
A Delaware pharmacy can fill a valid prescription if the product is in stock and the prescription meets state and federal requirements. Delaware's pharmacy regulations allow licensed pharmacies to exchange valid noncontrolled prescriptions, subject to recordkeeping and validity requirements [8]. A transfer needs authorized refills; otherwise, the pharmacy must request a new prescription.
A pharmacy located outside Delaware must hold a Delaware nonresident pharmacy permit before it ships, mails, or delivers a prescription drug to a patient in the state [9]. Before using a telehealth-linked mail pharmacy, verify the pharmacy's Delaware permit through the state's license system.
Delivery estimates depend on the prescriber, stock, insurance review, pharmacy processing, and carrier. The previous promises of a two-to-seven-day delivery and 24-to-72-hour PA decision were not supported by Delaware-wide evidence and have been removed.
When Compounded Tretinoin May Be Considered
Compounding is not automatically better or more effective than a commercially available tretinoin product. A patient-specific preparation may be considered when a prescriber identifies a clinical need that an available product does not meet, such as an ingredient sensitivity or a required formulation that is not commercially available.
Federal law places limits on compounding drugs that are essentially copies of commercially available products. FDA also explains that compounded products do not undergo premarket FDA review for safety, effectiveness, or quality [10].
Before filling compounded tretinoin:
- confirm the exact concentration and every active ingredient
- ask why an approved commercial product does not meet the need
- verify the pharmacy's Delaware resident or nonresident permit
- obtain storage instructions and the beyond-use date
- ask how to report a product-quality problem
Do not assume a trendy combination (such as tretinoin mixed with niacinamide, hydroquinone, or another prescription drug) is appropriate simply because a telehealth site sells it.
Using Topical Tretinoin Safely
Follow the directions for the dispensed product. Acne labels commonly direct a thin application to the affected area once daily, but the correct amount and frequency may be adjusted by the prescriber when irritation occurs [4].
Expected local reactions can include dryness, redness, peeling, burning, or stinging. Applying extra medication does not produce faster results and can increase irritation. Protect treated skin from excessive sunlight and use the sun-protection plan recommended by the clinician and product label.
Contact the prescriber for severe or persistent irritation, blistering, swelling, crusting, or a suspected allergic reaction. New or changing lesions, possible actinic keratoses, or concern for skin cancer require clinical evaluation rather than cosmetic tretinoin treatment.
The American Academy of Dermatology's current acne guideline supports topical retinoids as an evidence-based acne treatment class, but treatment should be individualized and often uses combinations with other therapies [11].
Choosing a Formulation
Cream, conventional gel, lotion, and microsphere gel are not interchangeable solely by matching the percentage on the label. Their vehicles, approved ages, indications, application directions, irritation profiles, and insurance status differ.
A clinician may consider:
- oily versus dry or sensitive skin
- the sites being treated
- prior irritation
- other topical products
- the formulation's labeled age range
- what the plan covers
There is clinical evidence that topical tretinoin can improve features of photodamaged skin, including a two-year randomized trial of 0.05% emollient cream [12]. That study does not make every generic acne product FDA approved for photoaging and does not prove that a stronger percentage is the best starting choice.
Frequently asked questions
How do I get a tretinoin prescription in Delaware?
Can an online provider prescribe tretinoin in Delaware?
Do I need blood tests before topical tretinoin?
Does Delaware Medicaid cover tretinoin?
Does Delaware Medicaid cover tretinoin for photoaging?
How long will a tretinoin prior authorization take?
Can I transfer tretinoin to a Delaware pharmacy?
Can an out-of-state pharmacy mail tretinoin to Delaware?
Is compounded tretinoin FDA approved?
Is tretinoin FDA approved for photoaging?
What tretinoin strength should I start with?
Is tretinoin sold over the counter in Delaware?
References
- Delaware Code, Title 24, Chapter 60. Provisions Applicable to Telehealth and Telemedicine. https://delcode.delaware.gov/title24/c060/index.html
- Delaware Code, Title 24, § 1935. Advanced Practice Registered Nurse authority and duties. https://delcode.delaware.gov/title24/c019/index.html
- Delaware Code, Title 24, Chapter 17, Subchapter VI. Physician associates. https://delcode.delaware.gov/title24/c017/sc06/index.html
- DailyMed. Tretinoin cream and gel prescribing information for acne vulgaris. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba377a5e-e48a-4bd9-9d76-929d70793396
- U.S. Food and Drug Administration. Retin-A Micro prescribing information, revised 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020475s029lbl.pdf
- DailyMed. RENOVA 0.02% prescribing information, updated February 2026. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f0a0e8d-1051-48a4-80c5-1bd260dd9c36
- Delaware Division of Medicaid and Medical Assistance. 2026 Delaware Medicaid Preferred Drug List, effective July 6, 2026. https://medicaidpublications.dhss.delaware.gov/docs/DesktopModules/Bring2mind/DMX/API/Entries/Download?Command=Core_Download&EntryId=940&PortalId=0&TabId=94&language=en-US
- Delaware Board of Pharmacy. Rules and Regulations, § 5.1.11, exchange of valid noncontrolled prescriptions between pharmacies. https://regulations.delaware.gov/api/AdminCode/title24/2500/e7256703-2449-42c9-a040-65754611335a
- Delaware Division of Professional Regulation. Non-Resident Pharmacy License. https://dpr.delaware.gov/boards/pharmacy/nonrespharmacy/
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. https://pubmed.ncbi.nlm.nih.gov/38300170/
- Kang S, Bergfeld W, Gottlieb AB, et al. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol. 2005;6(4):245-253. https://pubmed.ncbi.nlm.nih.gov/16060712/